Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma

BJU International

Volumn 108, Issue 5, 2011, Pages 762-770

  Safarinejad, Mohammad Reza ^a  

^a Private Practice of Urology and Andrology   (Iran)

Author keywords

insulin like growth factor binding protein 3; kidney; polymorphism; renal cell carcinoma

Indexed keywords

ADENINE; CYTOSINE; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLEAR CELL RENAL CELL CARCINOMA; CONTROLLED STUDY; ETHNIC GROUP; GENE DOSAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; IRANIAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; IRAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 80052023228     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.10017.x     Document Type: Article

References (37)

1. Dhote R, Pellicer-Coeuret M, Thiounn N, Debré B, Vidal-Trecan G,. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 2000; 86: 20-7 (Pubitemid 30420758)
2. Le Roith D,. Seminars in medicine of the Beth Israel Deaconess Medical Center Insulin-like growth factors. N Engl J Med 1997; 336: 633-40
3. Jones JI, Clemmons DR,. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev 1995; 16: 3-34
4. Dunn SE, Hardman RA, Kari FW, Barrett JC,. Insulin-like growth factor 1 (IGF-I) alters drug sensitivity of HBL 100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 1997; 57: 2687-93 (Pubitemid 27283781)
5. Parrizas M, LeRoith D,. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 1997; 138: 1355-8 (Pubitemid 27089798)
6. Tritos NA, Mantzoros CS,. Recombinant human growth hormone: old and novel uses. Am J Med 1998; 105: 44-57 (Pubitemid 28346109)
7. Harrela M, Koistinen H, Kaprio J, et al,. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996; 98: 2612-5 (Pubitemid 26415083)
8. Ehrenborg E, Larsson C, Stern I, et al,. Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7. Genomics 1992; 12: 497-502
9. Deal C, Ma J, Wilkin F, et al,. Novel promoter polymorphism in insulin-like growth factor binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 2001; 86: 1274-80 (Pubitemid 32323016)
10. Cubbage ML, Suwanichkul A, Powell DR,. Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. J Biol Chem 1990; 265: 12642-9
11. Jernström H, Deal C, Wilkin F, et al,. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 2001; 10: 377-84 (Pubitemid 32703223)
12. Toniolo P, Bruning PF, Akhmedkhanov A, et al,. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000; 88: 828-32
13. Krajcik RA, Borofsky ND, Massardo S, et al,. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomark Prev 2002; 11: 1566-73 (Pubitemid 36020008)
14. Goodwin PJ, Ennis M, Pritchard KI, et al,. Insulin like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res Treat 2002; 74: 65-76 (Pubitemid 34734598)
15. Chuang ST, Patton KT, Schafernak KT, et al,. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol 2008; 179: 445-9
16. Storkel S, Eble JN, Adlakha K, et al,. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 987-9
17. Miller SA, Dykes DD, Polesky HF,. A salting procedure for extracting DNA from nucleated cells. Nucleic Acid Res 1998; 16: 12-5
18. Fleiss J,. Statistical Methods for Rates and Proportion, Chapt 2. New York: John Wiley and Sons, 1981
19. Breslow NE, Day N, eds. Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies (IARC scientific publication no. 32). Lyon, France: International Agency for Research on Cancer, 1980
20. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN,. Polymorphic variation at the -202 locus in IGFBP-3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer 2003; 107: 60-4 (Pubitemid 37100086)
21. Wang L, Habuchi T, Tsuchiya N, et al,. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res 2003; 63: 4407-11 (Pubitemid 36951011)
22. Chen JC, Shao ZM, Sheikh MS, et al,. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 1994; 158: 69-78 (Pubitemid 24038422)
23. Pratt SE, Pollak MN,. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 1994; 198: 292-7 (Pubitemid 24172752)
24. Rosendahl AH, Forsberg G,. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Kidney Int 2006; 70: 1584-90 (Pubitemid 44606993)
25. Rosendahl A, Forsberg G,. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines. Int J Oncol 2004; 25: 1327-36
26. Rosendahl AH, Holly JM, Celander M, Forsberg G,. Systemic IGF-I administration stimulates the in vivo growth of early, but not advanced, renal cell carcinoma. Int J Cancer 2008; 123: 1286-91
27. Cheung CW, Vesey DA, Nicol DL, Johnson DW,. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 2004; 65: 1272
28. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW,. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11: 530-42
29. Hanafusa T, Yumoto Y, Nouso K, et al,. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett 2002; 176: 149-58 (Pubitemid 34136014)
30. Sun G, Chagnon M, Bouchard C,. A common polymorphism in the human insulin-like growth factor binding protein 3 gene. Mol Cell Probes 2000; 14: 55-6 (Pubitemid 30168908)
31. Hankinson SE, Willett WC, Colditz GA, et al,. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-6 (Pubitemid 28209997)
32. Baricević I, Masnikosa R, Lagundzin D, Golubović V, Nedić O,. Alterations of insulin-like growth factor binding protein 3 (IGFBP-3) glycosylation in patients with breast tumours. Clin Biochem 2010; 43: 725-31
33. Takahashi M, Yang XJ, Sugimura J, et al,. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003; 22: 6810-8 (Pubitemid 37372221)
34. Young AN, Amin MB, Moreno CS, et al,. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 2001; 158: 1639-51 (Pubitemid 32422929)
35. Takahashi M, Papavero V, Yuhas J, et al. Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 2005; 26: 923-31
36. Slipicevic A, Øy GF, Askildt IC, et al,. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions. Hum Pathol 2009; 40: 527-37
37. Smith PG, Day NE,. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol 1984; 13: 356-65 (Pubitemid 14004410)